Target intelligence / Profile preview

Daboia siamensis Kunitz-type serine protease inhibitor (KSPI)

Target
KSPI
Molecular classification
Kunitz-type protease inhibitor, Serine protease inhibitor, Toxin
01

Overview

Daboia siamensis Kunitz-type protease inhibitor toxins are a major family of small, disulfide-rich proteins (approximately 60 amino acids) found in the venom of the Eastern Russell's viper (UniProt A8Y7N5, P00990). These toxins function as potent inhibitors of various serine proteases, including trypsin, chymotrypsin, and plasmin, thereby disrupting the host's hemostatic system and contributing to severe coagulopathy and hemorrhage (PMC9325154, PMC7003344). While they are critical components of the venom's toxic profile, they also serve as the primary targets for neutralization by monovalent and polyvalent antivenoms during clinical treatment of snakebites (MDPI Toxins 2023, 15(1), 54). Beyond their role in envenomation, these Kunitz-type peptides are being actively researched for their potential therapeutic applications, particularly as anti-tumor and anti-angiogenic agents due to their ability to modulate signaling pathways and inhibit protease-mediated cell invasion (PMC8912144). However, their small size and low immunogenicity can pose significant challenges for achieving effective neutralization with standard antivenom therapies (PMC7003344).

Other names
Kunitz-type serine protease inhibitorVenom basic protease inhibitorTrypsin inhibitorChymotrypsin inhibitorBPTI-like toxinRVV-IIVKT2_DABSIVKTC2_DABSIVKTB3_DABSIVKTB1_DABSI
02

Mechanism of action

Antibody-mediated neutralization of toxin activity and competitive inhibition of host serine proteases.

03

Biological functions

Serine-type endopeptidase inhibitor activityToxin activityVenom-mediated perturbation of hemostasisProtease inhibitionInhibition of trypsin, chymotrypsin, and plasmin
04

Disease associations

Snakebite envenomationCoagulopathyHemorrhageCancer
05

Safety considerations

Low immunogenicity leading to poor antivenom neutralizationRisk of antivenom-induced hypersensitivityRapid systemic absorption
06

Interacting drugs

Russell's Viper Monovalent Antivenom

2 more in the full profile.

07

Biomarkers

Prothrombin time (PT)Activated partial thromboplastin time (aPTT)Fibrinogen levelVenom antigen level

Beyond the preview

Go deeper on Daboia siamensis Kunitz-type serine protease inhibitor (KSPI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia siamensis Kunitz-type serine protease inhibitor (KSPI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call